Clinical Trial: Gynecomastia Extension Study

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: An OptioExtension of Trial 1033US/0006 to Assess Safety, Tolerability, Efficacy of Anastrozole (ZD1033, Arimidex™) in Treatment of Gynecomastia in Pubertal Boys Give

Brief Summary: The purpose of this study is to look at the effect of anastrozole (ZD1033, Arimidex™) in reducing gynecomastia in pubertal boys treated with placebo in Trial 1033US/0006 (another anastrozole study).

Detailed Summary:
Sponsor: AstraZeneca

Current Primary Outcome: Change in linear dimensions of the breast

Original Primary Outcome: Same as current

Current Secondary Outcome: Change in breast tenderness

Original Secondary Outcome: Same as current

Information By: AstraZeneca

Dates:
Date Received: March 7, 2008
Date Started: January 2001
Date Completion:
Last Updated: March 10, 2008
Last Verified: March 2008